Physician profile
Harold W Jackson
NPI 1235126475
$2,660.30
in general payments reported to CMS, 2019-2025
20 companies · $44.51 in 2025
The $44.51 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $363 · 2020: $75.44 · 2021: $86.65 · 2022: $2,050 · 2023: $40.25 · 2025: $44.51.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $1,920.44 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $103.89 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $67.00 | 2021 | |
| Scilex Pharmaceuticals INC. | $64.87 | 2019 | |
| Xeris Pharmaceuticals, INC. | $63.79 | 2022-2025 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $58.18 | 2019-2021 | |
| Amgen INC. | $55.89 | 2019 | |
| Glaxosmithkline, LLC. | $46.92 | 2022-2023 | Arexvy |
| Kaleo, INC. | $46.15 | 2019 | |
| Novo Nordisk INC | $40.75 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $28.88 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $23.41 | 2025 | Dupixent |
| Emergent Biosolutions INC. | $23.19 | 2019 | |
| Almatica Pharma LLC | $21.57 | 2022 | |
| Gilead Sciences, INC. | $19.21 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $18.99 | 2022 | |
| Janssen Pharmaceuticals, INC | $15.69 | 2019 | |
| Philips North America LLC | $14.12 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $13.97 | 2022 | |
| Sanofi Pasteur INC. | $13.39 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Jackson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.